ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells-Reference-Cited by-同舟云学术

ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells

Published:2022-05-16 Issue:1 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhang Xiao¹,Bai Yaping²,Zhu Wenhao²,Lv Xinyue²,Pei Wenjun²

Affiliation:

1. Department of Pediatric Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, P.R. China

2. Anhui Province Key Laboratory of Biological Macro‑Molecules Research, Wannan Medical College, Wuhu, Anhui 241001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference33 articles.

1. Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications;Chao;Am J Transl Res,2020

2. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-snail axis;Jiang;Proc Natl Acad Sci USA,2020

3. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2021

4. TAp73-induced phosphofructokinase-1 transcription promotes the warburg effect and enhances cell proliferation;Li;Nat Commun,2018

5. Glutamine and cancer: Cell biology, physiology, and clinical opportunities;Hensley;J Clin Invest,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of APOM gene in liver cancer: Investigating the impact of hsa-miR-4489/MUC1-mediated ferroptosis on the advancement of hepatocellular carcinoma cells;Gene;2024-10

2. Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma;Hepatology Forum;2024

3. Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients;Breast Cancer Research and Treatment;2023-07-25

4. Apolipoproteins: New players in cancers;Frontiers in Pharmacology;2022-11-25